Michael Murawsky

699 total citations
23 papers, 564 citations indexed

About

Michael Murawsky is a scholar working on Pharmaceutical Science, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael Murawsky has authored 23 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmaceutical Science, 8 papers in Molecular Biology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael Murawsky's work include Cardiac electrophysiology and arrhythmias (8 papers), Advancements in Transdermal Drug Delivery (6 papers) and Advanced Drug Delivery Systems (6 papers). Michael Murawsky is often cited by papers focused on Cardiac electrophysiology and arrhythmias (8 papers), Advancements in Transdermal Drug Delivery (6 papers) and Advanced Drug Delivery Systems (6 papers). Michael Murawsky collaborates with scholars based in United States. Michael Murawsky's co-authors include David Rampe, Eric Lewis, Javier Grau, S. Kevin Li, Alain Carpentier, Stéphane Carpentier, Gina M. Fadayel, Gerald B. Kasting, Qian Zhang and John M. Janusz and has published in prestigious journals such as Brain Research, Endocrinology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michael Murawsky

23 papers receiving 529 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Murawsky United States 13 264 207 107 93 83 23 564
Maryam Shayan Iran 12 122 0.5× 92 0.4× 22 0.2× 55 0.6× 16 0.2× 38 466
Jesús Llenas Spain 13 235 0.9× 74 0.4× 68 0.6× 56 0.6× 9 0.1× 28 548
Dan Luo China 17 180 0.7× 13 0.1× 83 0.8× 18 0.2× 43 0.5× 47 645
Akiyoshi Tani Japan 13 234 0.9× 97 0.5× 108 1.0× 86 0.9× 6 0.1× 21 564
Ivano Rondelli Italy 8 56 0.2× 27 0.1× 27 0.3× 53 0.6× 90 1.1× 13 344
Hongyu Xu China 10 256 1.0× 15 0.1× 24 0.2× 39 0.4× 73 0.9× 19 510
Margarida Duarte‐Araújo Portugal 12 100 0.4× 75 0.4× 11 0.1× 45 0.5× 60 0.7× 30 418
William B. Wastila United States 13 225 0.9× 55 0.3× 43 0.4× 106 1.1× 8 0.1× 28 589
Rajamannar Thennati India 11 149 0.6× 15 0.1× 34 0.3× 94 1.0× 14 0.2× 23 513
James Wakefield United States 12 227 0.9× 44 0.2× 32 0.3× 47 0.5× 12 0.1× 26 626

Countries citing papers authored by Michael Murawsky

Since Specialization
Citations

This map shows the geographic impact of Michael Murawsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Murawsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Murawsky more than expected).

Fields of papers citing papers by Michael Murawsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Murawsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Murawsky. The network helps show where Michael Murawsky may publish in the future.

Co-authorship network of co-authors of Michael Murawsky

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Murawsky. A scholar is included among the top collaborators of Michael Murawsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Murawsky. Michael Murawsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murawsky, Michael, et al.. (2023). Permeability of Fresh and Frozen Porcine and Human Gingiva and the Effect of Storage Duration. Pharmaceutics. 15(5). 1492–1492. 2 indexed citations
2.
Murawsky, Michael, et al.. (2023). Iontophoresis on Porcine and Human Gingiva. Pharmaceutical Research. 40(8). 1977–1987. 1 indexed citations
3.
Murawsky, Michael, et al.. (2022). Characterization of Porcine Gingiva for Drug Absorption. Journal of Pharmaceutical Sciences. 112(4). 1032–1040. 6 indexed citations
4.
Murawsky, Michael, et al.. (2022). Modification of small dissolution chamber system for long-acting periodontal drug product evaluation. International Journal of Pharmaceutics. 618. 121646–121646. 8 indexed citations
5.
Zhang, Qian, Michael Murawsky, Jinsong Hao, et al.. (2020). Evaluation of Heat Effects on Fentanyl Transdermal Delivery Systems Using In Vitro Permeation and In Vitro Release Methods. Journal of Pharmaceutical Sciences. 109(10). 3095–3104. 9 indexed citations
6.
Zhang, Qian, Michael Murawsky, Jinsong Hao, et al.. (2020). Evaluation of Heat Effects on Transdermal Nicotine Delivery In Vitro and In Silico Using Heat-Enhanced Transport Model Analysis. The AAPS Journal. 22(4). 82–82. 8 indexed citations
7.
Wei, Ren, Michael Murawsky, Gary R. Kelm, et al.. (2019). Dissolution Chamber for Small Drug Delivery System in the Periodontal Pocket. The AAPS Journal. 21(3). 51–51. 7 indexed citations
8.
Zhang, Qian, et al.. (2018). Transepidermal water loss and skin conductance as barrier integrity tests. Toxicology in Vitro. 51. 129–135. 50 indexed citations
9.
Zhang, Qian, Michael Murawsky, Jinsong Hao, et al.. (2017). Characterization of Temperature Profiles in Skin and Transdermal Delivery System When Exposed to Temperature Gradients In Vivo and In Vitro. Pharmaceutical Research. 34(7). 1491–1504. 15 indexed citations
10.
11.
Wu, Shengde, et al.. (2006). Discovery and synthesis of tetrahydroindolone-derived carbamates as Kv1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 16(22). 5855–5858. 19 indexed citations
12.
Jackson, C. M., Benjamin E. Blass, Gina M. Fadayel, et al.. (2006). Evolution of thiazolidine-based blockers of human Kv1.5 for the treatment of atrial arrhythmias. Bioorganic & Medicinal Chemistry Letters. 17(1). 282–284. 32 indexed citations
13.
Wu, Shengde, John M. Janusz, Benjamin E. Blass, et al.. (2006). Discovery and synthesis of tetrahydroindolone derived semicarbazones as selective Kv1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 16(22). 5859–5863. 31 indexed citations
14.
Wu, Shengde, John M. Janusz, Benjamin E. Blass, et al.. (2006). Discovery and in vitro/in vivo studies of tetrazole derivatives as Kv1.5 blockers. Bioorganic & Medicinal Chemistry Letters. 16(24). 6213–6218. 49 indexed citations
15.
Blass, Benjamin E., Wenlin Lee, Neil T. Fairweather, et al.. (2006). Synthesis and evaluation of (2-phenethyl-2H-1,2,3-triazol-4-yl)(phenyl)methanones as Kv1.5 channel blockers for the treatment of atrial fibrillation. Bioorganic & Medicinal Chemistry Letters. 16(17). 4629–4632. 27 indexed citations
16.
Murawsky, Michael, et al.. (2004). Solid support membranes for ion channel arrays and sensors: application to rapid screening of pharmacological compounds. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1665(1-2). 184–190. 6 indexed citations
17.
Rampe, David, Michael Murawsky, Javier Grau, & Eric Lewis. (1998). The Antipsychotic Agent Sertindole is a High Affinity Antagonist of the Human Cardiac Potassium Channel HERG. Journal of Pharmacology and Experimental Therapeutics. 286(2). 788–793. 142 indexed citations
18.
Baron, Bruce M., Boyd L. Harrison, John H. Kehne, et al.. (1997). Pharmacological characterization of MDL 105,519, an NMDA receptor glycine site antagonist. European Journal of Pharmacology. 323(2-3). 181–192. 40 indexed citations
19.
Rampe, David & Michael Murawsky. (1997). Blockade of the human cardiac K+ channel Kv1.5 by the antibiotic erythromycin. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(6). 743–750. 19 indexed citations
20.
Wible, Barbara A., Michael Murawsky, William Crumb, & David Rampe. (1997). Stable expression and characterization of the human brain potassium channel Kv2.1: blockade by antipsychotic agents. Brain Research. 761(1). 42–50. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maryam Shayan Breakdown of academic impact, for papers by Jesús Llenas Breakdown of academic impact, for papers by Dan Luo Breakdown of academic impact, for papers by Akiyoshi Tani Breakdown of academic impact, for papers by Ivano Rondelli Breakdown of academic impact, for papers by Hongyu Xu Breakdown of academic impact, for papers by Margarida Duarte‐Araújo Breakdown of academic impact, for papers by William B. Wastila Breakdown of academic impact, for papers by Rajamannar Thennati Breakdown of academic impact, for papers by James Wakefield
Rankless by CCL
2026